Last reviewed · How we verify

NCT05481567

Periodontitis Stage III and IV and Oral Health Related Quality of Life

Status unknown Last updated 1 August 2022
What this trial tests

trial testing Questionnaire in Periodontitis in 100 participants. Status unknown.

Timeline
1 September 2022
Primary endpoint
30 June 2023
30 June 2023

Quick facts

Lead sponsorUniversity of Cagliari
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 September 2022
Primary completion30 June 2023
Estimated completion30 June 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Cagliari

Who can join

Eligibility, any sex, with Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients diagnosed with stage III or IV periodontitis during routine visits at the department of periodontology will undergo a validated questionnaire to understand the impact of the disease on their quality of life.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other University of Cagliari trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05481567.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing